Mr. Michael P Watta PA-C

Recommended Articles

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• Is Bronchitis Contagious?

  Is bronchitis contagious? In most cases, only acute bronchitis is contagious. Learn more about when bronchitis is contagious, and how to prevent it from spreading.What is bronchitis?Tubes made of glandular goblet cells that direct air into your lungs, also known as bronchi, are located below the...

• COPD: Can Obesity Make it Worse?

  It is clear that obesity can lead to future health complications, now including chronic obstructive pulmonary disease (COPD). It has been established that there is a link between obesity and COPD, as obesity can further complicate the symptoms of COPD.Obesity can be easily computed through BMI...

• What Is Paroxysmal Atrial Fibrillation?

  What Is Paroxysmal Atrial Fibrillation?Paroxysmal is a condition derived from atrial fibrillation. Atrial fibrillation (AFib) refers to abnormal heartbeats. These impulses are not just irregular heartbeats, but appear as vibrations in the atria chamber of the heart. Once a person suffers from the...

• The Signs and Symptoms of Pneumonia

  ...

• A Cystic Fibrosis App to Bring Data to Market

  For many people with CF, remembering their daily treatment regimens and medication schedules can seem daunting and difficult. Most patients acclaim that if they had a resource, such as an app, that would make their health management easier to handle, that they would love to try it. In addition to...